Overview
Jeffrey Weitzel is a Hematologist Oncology specialist and a Hematologist in Kansas City, Kansas. Dr. Weitzel is rated as an Experienced provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Breast Cancer, Ovarian Cancer, Li-Fraumeni Syndrome, Breast Cancer in Men, and Salpingo-Oophorectomy. Dr. Weitzel is currently accepting new patients.
His clinical research consists of co-authoring 223 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Aplastic Anemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Select Physical Therapy Holdings Inc
Marc Hoffmann is a Hematologist Oncology specialist and a Hematologist in Independence, Missouri. Dr. Hoffmann is rated as a Distinguished provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration. Dr. Hoffmann is currently accepting new patients.
The University Of Kansas Health System - Clinical Research Center
Abdulraheem Yacoub is a Hematologist in Fairway, Kansas. Dr. Yacoub is rated as an Elite provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Polycythemia Vera, Myelofibrosis, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Yacoub is currently accepting new patients.
University Of Kansas Hospital Authority
Joseph Mcguirk is a Hematologist Oncology specialist and a Hematologist in Westwood, Kansas. Dr. Mcguirk is rated as a Distinguished provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mcguirk is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Weitzel isElite. Learn about Breast Cancer.
- Distinguished
- Li-Fraumeni SyndromeDr. Weitzel isDistinguished. Learn about Li-Fraumeni Syndrome.
- Ovarian CancerDr. Weitzel isDistinguished. Learn about Ovarian Cancer.
- Advanced
- Breast Cancer in MenDr. Weitzel isAdvanced. Learn about Breast Cancer in Men.
- Familial Colorectal CancerDr. Weitzel isAdvanced. Learn about Familial Colorectal Cancer.
- Lynch SyndromeDr. Weitzel isAdvanced. Learn about Lynch Syndrome.
- Ring Chromosome 12Dr. Weitzel isAdvanced. Learn about Ring Chromosome 12.
- Salpingo-OophorectomyDr. Weitzel isAdvanced. Learn about Salpingo-Oophorectomy.
- Triple-Negative Breast CancerDr. Weitzel isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- AngiosarcomaDr. Weitzel isExperienced. Learn about Angiosarcoma.
- Aplastic AnemiaDr. Weitzel isExperienced. Learn about Aplastic Anemia.
- BRCA Positive Breast CancerDr. Weitzel isExperienced. Learn about BRCA Positive Breast Cancer.
- Colorectal CancerDr. Weitzel isExperienced. Learn about Colorectal Cancer.
- Congenital Aplastic AnemiaDr. Weitzel isExperienced. Learn about Congenital Aplastic Anemia.
- Familial Pancreatic CancerDr. Weitzel isExperienced. Learn about Familial Pancreatic Cancer.